Liven Pharma Cash Flow Statement

Financials in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2016 - 2020
Net Income	-584.46	41.74	-12.33	-14.29	-14.63	Upgrade
Depreciation & Amortization	27.17	24.87	13.1	14.56	16.08	Upgrade
Other Amortization	328.27	0.69	-	-	-	Upgrade
Provision & Write-off of Bad Debts	116.87	-	-	-	-	Upgrade
Other Operating Activities	92.58	1.15	-2.9	-3.22	-3.55	Upgrade
Change in Accounts Receivable	-21.52	-42.29	-	-	-	Upgrade
Change in Inventory	0.46	-11.82	-	-	-	Upgrade
Change in Accounts Payable	39.43	0.21	-	-0.07	-4.16	Upgrade
Change in Other Net Operating Assets	-0.52	-0.75	-0.14	0.76	-0.52	Upgrade
Operating Cash Flow	-1.72	13.8	-2.27	-2.26	-6.79	Upgrade
Capital Expenditures	-22.84	-	-	-	-	Upgrade
Sale (Purchase) of Intangibles	-10	-	-	-	-	Upgrade
Investing Cash Flow	-32.84	-	-	-	-	Upgrade
Short-Term Debt Issued	168.72	11.34	2.27	2.24	6.79	Upgrade
Long-Term Debt Issued	6.68	1.36	-	-	-	Upgrade
Total Debt Issued	175.4	12.7	2.27	2.24	6.79	Upgrade
Short-Term Debt Repaid	-156.14	-	-	-	-	Upgrade
Long-Term Debt Repaid	-1.8	-3.54	-	-	-	Upgrade
Total Debt Repaid	-157.94	-3.54	-	-	-	Upgrade
Net Debt Issued (Repaid)	17.46	9.16	2.27	2.24	6.79	Upgrade
Financing Cash Flow	17.46	9.16	2.27	2.24	6.79	Upgrade
Miscellaneous Cash Flow Adjustments	0.03	-	-	-	-	Upgrade
Net Cash Flow	-17.07	22.96	0	-0.02	-0.01	Upgrade
Free Cash Flow	-24.56	13.8	-2.27	-2.26	-6.79	Upgrade
Free Cash Flow Margin	-19.30%	5.63%	-	-	-	Upgrade
Free Cash Flow Per Share	-0.35	345.08	-0.19	-0.19	-0.56	Upgrade
Cash Interest Paid	0.47	0.1	-	-	-	Upgrade
Levered Free Cash Flow	151.56	-163.82	3.45	4.31	0.03	Upgrade
Unlevered Free Cash Flow	152.02	-163.81	3.45	4.31	0.03	Upgrade
Change in Working Capital	17.84	-54.65	-0.14	0.7	-4.69	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.